Rocuronium bromide
-
- Application
- Inhibition Assay (InhA), Functional Studies (Func)
- Purpose
- Rocuronium (rapid onset-curonium) is a desacetoxy analogue of vecuronium with a more rapid onset of action. It is an aminosteroid non-depolarizing neuromuscular blocker or muscle relaxant used in modern anaesthesia, to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation. Introduced in 1994, rocuronium has rapid onset, and intermediate duration of action. It is marketed under the trade name of Zemuron in the United States and Esmeron in most other countries.
- Characteristics
-
Tradename: SALONPAS
Source of Compound: synthetic
Target: AChR antagonist
Receptor: Muscarinic AChR
- Purification
- All the products are sent with COA, HPLC and NMR inspection report to guarantee the quality.
- Purity
- 99 %
- Formula
- C32H53BrN2O4
- Solubility
- Soluble in water
-
-
- Application Notes
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Solid
- Storage
- -20 °C
- Storage Comment
-
For the majority of compounds, they could be dissolved in DMSO or other organic solvent.
Their stock solution can be stored at -20°C for up to 3 months and aliquoted for sampling convenience.
Several freeze/thaw cycles should not damage the activity of our small molecule products.
However, in many instances the aqueous solutions of some compounds need to be made fresh and cannot be stored. For these compounds, their solution should be prepared just before use and stored no longer than 24 hours. - Expiry Date
- 24 months
-
- Background
- Neuroscience
- Molecular Weight
- 609.68 g/mol
- CAS-No
- 119302-91-9
-